Who
Rahul Khara
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Disc Medicine.
In numbers
- Trades disclosed
- 76
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $5.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2022
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $73K5,000 at $14.69 | filing |
| 6 Aug 2026filed 7 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $400K5,000 at $80.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $73K5,000 at $14.69 | filing |
| 6 Aug 2026filed 7 Aug 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $400K5,000 at $80.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $24K1,649 at $14.69 | filing |
| 29 Jun 2026filed 30 Jun 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,649 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $124K1,649 at $75.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,649 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $24K1,649 at $14.69 | filing |
| 29 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $124K1,649 at $75.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $13K851 at $14.69 | filing |
| 26 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $64K851 at $75.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —851 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | IRON Disc Medicineoption or derivative · Biotechnology | SEC FORM 4 Code M | —851 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $13K851 at $14.69 | filing |
| 26 Jun 2026filed 30 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $64K851 at $75.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Code M | $110K7,500 at $14.69 | filing |
| 18 Jun 2026filed 23 Jun 2026 | IRON Disc MedicineBiotechnology | SEC FORM 4 Sold | $378K5,400 at $69.94 | filing |
News
Disc Medicine (NASDAQ:IRON) Director Sells 10,994 Shares of StockIRON · themarketsdaily.com · 21 Oct 2026Disc Medicine Prices $450 Mln Offering Of Shares At $75/shr To Fund Pipeline DevelopmentIRON · finanzen.ch · 21 Oct 2026Disc Medicine Launches $350M Stock Offering Following Positive Phase 3 ResultsIRON · rttnews.com · 20 Oct 2026
0 headlines in the last 90 days name Rahul Khara; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.